<SEC-DOCUMENT>0000950103-25-016375.txt : 20251219
<SEC-HEADER>0000950103-25-016375.hdr.sgml : 20251219
<ACCEPTANCE-DATETIME>20251219144342
ACCESSION NUMBER:		0000950103-25-016375
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		15
FILED AS OF DATE:		20251219
DATE AS OF CHANGE:		20251219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ROYAL BANK OF CANADA
		CENTRAL INDEX KEY:			0001000275
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				135357855
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-275898
		FILM NUMBER:		251587023

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		ROYAL BANK PLAZA
		STREET 2:		200 BAY STREET
		CITY:			TORONTO
		PROVINCE COUNTRY:   	A6
		ZIP:			M5J 2J5
		BUSINESS PHONE:		212-437-9267

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		ROYAL BANK PLAZA
		STREET 2:		200 BAY STREET
		CITY:			TORONTO
		PROVINCE COUNTRY:   	A6
		ZIP:			M5J 2J5

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ROYAL BANK OF CANADA \
		DATE OF NAME CHANGE:	19950908
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp238986_424b2wfceln352amzn.htm
<DESCRIPTION>FORM 424B2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="width: 60%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">PRICING SUPPLEMENT dated December 17, 2025</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">(To the Product Supplement No. WF1 dated December
    20, 2023 and the Prospectus Supplement and the Prospectus, each dated December 20, 2023)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></P></TD>
    <TD STYLE="white-space: nowrap; width: 40%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Registration Statement No. 333-275898</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Filed Pursuant to Rule 424(b)(2)</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 12pt Calibri, Helvetica, Sans-Serif; text-align: right"><IMG SRC="image_003.jpg" ALT=""></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EDEFEE">
    <TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 98%">
    <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Royal Bank of Canada</B></P>
    <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"></P>
    <P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Senior Global Medium-Term
    Notes, Series J</B></P>
    <P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"></P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #D5D9D8">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>
    <P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>$873,000 Market Linked Securities&mdash;Contingent
    Fixed Return and Contingent Downside</B></P>
    <P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Common
    Stock of Amazon.com, Inc. due June 22, 2027</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #5E8AB4">
    <TD STYLE="width: 100%">
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 3.4pt 0pt 0.2in; text-align: justify; text-indent: -0.2in; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;Linked
    to the common stock of Amazon.com, Inc. (the &ldquo;<U>Underlying Stock</U>&rdquo;)</FONT></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 3.4pt 0pt 0.2in; text-align: justify; text-indent: -0.2in; color: white"></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 3.4pt 0pt 0.2in; text-align: justify; text-indent: -0.2in; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;Unlike
    ordinary debt securities, the securities do not pay interest or repay a fixed amount of principal at maturity. Instead, the securities
    provide for a maturity payment amount that may be greater than or less than the face amount of the securities, depending on the performance
    of the Underlying Stock from the starting value to the ending value. The maturity payment amount will reflect the following terms:</FONT></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 3.4pt 0pt 0.2in; text-align: justify; text-indent: -0.2in; color: white"></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 3.4pt 0pt 30.5pt; text-align: justify; text-indent: -16.1pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT>
    <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;If the value of the Underlying Stock increases, remains flat or decreases, but
    the decrease is not more than 15%, you will receive the face amount <I>plus</I> a contingent fixed return of 26.00% of the face amount.</FONT></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 3.4pt 0pt 30.5pt; text-align: justify; text-indent: -16.1pt; color: white"></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 3.4pt 0pt 30.5pt; text-align: justify; text-indent: -16.1pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT>
    <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;If the value of the Underlying Stock decreases by more than 15%, you will have
    full <FONT STYLE="background-color: #5E8AB4">downside exposure to the decrease in the value of the Underlying Stock from the starting
    value, and you will lose more than 15%, and possibly all, of the face amount of your securities.</FONT></FONT></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 3.4pt 0pt 30.5pt; text-align: justify; text-indent: -16.1pt; color: white"></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 3.4pt 0pt 0.2in; text-align: justify; text-indent: -0.2in; color: white"><FONT STYLE="font-family: Wingdings">n</FONT>
    <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;Investors may lose a significant portion,
    or all, of the face amount.</FONT></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 3.4pt 0pt 0.2in; text-align: justify; text-indent: -0.2in; color: white"></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 3.4pt 0pt 0.2in; text-align: justify; text-indent: -0.2in; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;Any
    positive return on the securities at maturity will be limited to the contingent fixed return, regardless of any increase in the value
    of the Underlying Stock.</FONT></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 3.4pt 0pt 0.2in; text-align: justify; text-indent: -0.2in; color: white"></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 3.4pt 0pt 0.2in; text-align: justify; text-indent: -0.2in; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;All
    payments on the securities are subject to credit risk, and you will have no ability to pursue the issuer of the Underlying Stock for payment;
    if Royal Bank of Canada, as issuer, defaults on its obligations, you could lose some or all of your investment.</FONT></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 3.4pt 0pt 0.2in; text-align: justify; text-indent: -0.2in; color: white"></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 3.4pt 0pt 0.2in; text-align: justify; text-indent: -0.2in; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;No
    periodic interest payments or dividends</FONT></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 3.4pt 0pt 0.2in; text-align: justify; text-indent: -0.2in; color: white"></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 3.4pt 0pt 0.2in; text-align: justify; text-indent: -0.2in; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;No
    exchange listing; designed to be held to maturity</FONT></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 3.4pt 0pt 0.2in; text-align: justify; text-indent: -0.2in; color: white"></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>The initial estimated value of the securities
determined by us as of the pricing date, which we refer to as the initial estimated value, is $978.12 per security and is less than the
original offering price of the securities. The market value of the securities at any time will reflect many factors, cannot be predicted
with accuracy and may be less than this amount. We describe the determination of the initial estimated value in more detail below.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>The securities have complex features and investing
in the securities involves risks not associated with an investment in conventional debt securities. See &ldquo;Selected Risk Considerations&rdquo;
beginning on page PS-8 herein and &ldquo;Risk Factors&rdquo; beginning on page PS-5 of the accompanying product supplement.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>The securities are the unsecured obligations
of Royal Bank of Canada, and, accordingly, all payments on the securities are subject to the credit risk Royal Bank of Canada. If Royal
Bank of Canada, as issuer, defaults on its obligations, you could lose some or all of your investment.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>None of the Securities and Exchange Commission
(the &ldquo;<U>SEC</U>&rdquo;), any state securities commission or any other regulatory body has approved or disapproved of the securities
or passed upon the adequacy or accuracy of this pricing supplement. Any representation to the contrary is a criminal offense. The securities
will not constitute deposits insured by the Canada Deposit Insurance Corporation, the U.S. Federal Deposit Insurance Corporation or any
other Canadian or U.S. governmental agency or instrumentality. The securities are not bail-inable notes and are not subject to conversion
into our common shares under subsection 39.2(2.3) of the Canada Deposit Insurance Corporation Act.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 23%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 29%; border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Original Offering Price</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 24%; border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Agent Discount<SUP>(1)(2)</SUP></B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 24%; border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proceeds to Royal Bank of Canada</B></FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; font: 12pt Calibri, Helvetica, Sans-Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per Security</B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$23.25</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$976.75</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; font: 12pt Calibri, Helvetica, Sans-Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$873,000</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$20,297.25</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$852,702.75</FONT></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 12.25pt"><SUP>(1)</SUP></TD><TD STYLE="text-align: justify">Wells Fargo Securities, LLC is the agent for the distribution of the securities and is acting as principal.
See &ldquo;Terms of the Securities&mdash;Agent&rdquo; and &ldquo;Estimated Value of the Securities&rdquo; in this pricing supplement for
further information.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 12.25pt"><SUP>(2)</SUP></TD><TD STYLE="text-align: justify">In addition to the forgoing, in respect of certain securities sold in this offering, our affiliate, RBC
Capital Markets, LLC (&ldquo;<U>RBCCM</U>&rdquo;), may pay a fee of up to $1.00 per security to selected securities dealers in consideration
for marketing and other services in connection with the distribution of the securities to other securities dealers.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Wells Fargo Securities</B></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Market
Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</B></FONT></P>

<P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P>

<P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Principal
at Risk Securities Linked to the Common Stock of Amazon.com, Inc. due June 22, 2027</B></FONT></P>

<P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #5E8AB4">
    <TD COLSPAN="2" STYLE="padding-top: 3pt; font: 12pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Terms
    of the Securities</B></FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; width: 23%; background-color: #D9D9D6; font: 12pt Times New Roman, Times, Serif; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issuer:</B></FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-left: 4pt; width: 77%; font: 12pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royal Bank of Canada </FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; border-bottom: white 1pt solid; font: 12pt Times New Roman, Times, Serif; background-color: #D9D9D6; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="padding-top: 3pt; padding-left: 4pt; font: 12pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The common stock of Amazon.com, Inc. (the &ldquo;<U>Underlying Stock</U>&rdquo;)</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD ROWSPAN="2" STYLE="border-right: Black 1pt solid; text-align: left; width: 23%; background-color: rgb(217,217,214); vertical-align: middle"><B>Market Measure:</B></P>

<P STYLE="margin: 0pt 0; font: 10pt Georgia, Times, Serif"></TD>
    <TD STYLE="width: 27%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Bloomberg Ticker Symbol</B></FONT></TD>
    <TD STYLE="width: 25%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Starting Value<SUP>(a)</SUP></B></FONT></TD>
    <TD STYLE="width: 25%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Threshold Value<SUP>(</SUP></B><SUP>b<B>)</B></SUP></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AMZN UW</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$221.27</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$188.0795</FONT></TD></TR>
  </TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="border-bottom: rgb(217,217,214) 1pt solid; padding-top: 3pt; width: 23%; background-color: #D9D9D6; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="padding-top: 3pt; padding-left: 4pt; width: 77%; text-align: justify; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(a)</SUP> The closing value of the Underlying Stock on the pricing date</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; border-bottom: white 1pt solid; background-color: #D9D9D6; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="padding-top: 3pt; padding-left: 4pt; text-align: justify; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(b)</SUP> 85% of the starting value</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; border-bottom: white 1pt solid; background-color: #D9D9D6; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pricing Date:</B></FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-left: 4pt; text-align: justify; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 17, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; border-bottom: white 1pt solid; background-color: #D9D9D6; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issue Date:</B></FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-left: 4pt; text-align: justify; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 22, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; border-bottom: white 1pt solid; background-color: #D9D9D6; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Calculation Day*:</B></FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-left: 4pt; text-align: justify; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 17, 2027</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; border-bottom: white 1pt solid; background-color: #D9D9D6; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stated Maturity Date*:</B></FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-left: 4pt; text-align: justify; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 22, 2027</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; border-bottom: white 1pt solid; background-color: #D9D9D6; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Face Amount:</B></FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-left: 4pt; text-align: justify; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,000 per security. References in this pricing supplement to a &ldquo;<U>security</U>&rdquo; are to a security with a face amount of $1,000.</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; background-color: #D9D9D6; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maturity Payment Amount:</B></FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-left: 4pt; vertical-align: top; padding-bottom: 3pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you will be entitled to receive
    a cash payment per security in U.S. dollars equal to the maturity payment amount. The &ldquo;<U>maturity payment amount</U>&rdquo; per
    security will equal:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT><FONT STYLE="font-size: 10pt">if the ending value is greater than or equal to the threshold value: $1,000 <I>plus</I> the contingent
    fixed return; or</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT><FONT STYLE="font-size: 10pt">if the ending value is less than the threshold value:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.35pt; text-align: center">$1,000 + ($1,000 &times; stock
return)&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If the ending value is less than the threshold value,
    you will have full downside exposure to the decrease in the value of the Underlying Stock from the starting value, and you will lose more
    than 15%, and possibly all, of the face amount of your securities at maturity.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; border-top: white 1pt solid; border-bottom: white 1pt solid; background-color: #D9D9D6; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contingent Fixed Return:</B></FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-left: 4pt; text-align: justify; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The &ldquo;<U>contingent fixed return</U>&rdquo; is 26.00% of the face amount per security ($260.00 per security). As a result of the contingent fixed return, any positive return on the securities at maturity will be limited to 26.00% of the face amount. The contingent fixed return is payable only if the ending value is greater than or equal to the threshold value.</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; border-bottom: white 1pt solid; background-color: #D9D9D6; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock Return:</B></FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-left: 4pt; padding-bottom: 3pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The &ldquo;<U>stock return</U>&rdquo; is the percentage
    change from the starting value to the ending value, calculated as follows:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.05pt 0pt 0; text-align: center"><U>ending value &ndash; starting
value</U>&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">starting value&nbsp;</P></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; border-bottom: white 1pt solid; background-color: #D9D9D6; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Closing Value:</B></FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-left: 4pt; vertical-align: top; text-align: justify; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing value</U>&rdquo; has the meaning assigned to &ldquo;stock closing price&rdquo; set forth under &ldquo;General Terms of the Securities&mdash;Certain Terms for Securities Linked to an Underlying Stock&mdash;Certain Definitions&rdquo; in the accompanying product supplement. The closing value of the Underlying Stock is subject to adjustment through the adjustment factor as described in the accompanying product supplement.</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; border-bottom: white 1pt solid; background-color: #D9D9D6; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ending Value:</B></FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-left: 4pt; text-align: justify; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The &ldquo;<U>ending value</U>&rdquo; will be the closing value of the Underlying Stock on the calculation day.</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; border-bottom: white 1pt solid; background-color: #D9D9D6; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Calculation Agent:</B></FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-left: 4pt; text-align: justify; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RBC Capital Markets, LLC (&ldquo;<U>RBCCM</U>&rdquo;)</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; border-bottom: white 1pt solid; background-color: #D9D9D6; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Material Tax Consequences:</B></FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-left: 4pt; text-align: justify; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For a discussion of the material U.S. federal income and certain estate tax consequences of the ownership and disposition of the securities, see the discussions in &ldquo;United States Federal Income Tax Considerations&rdquo; below and in the section entitled &ldquo;United States Federal Tax Considerations&rdquo; in the product supplement. For a discussion of the material Canadian federal income tax consequences relating to the securities, please see the section of the product supplement, &ldquo;Canadian Federal Income Tax Consequences.&rdquo;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</B></FONT></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Principal at Risk Securities Linked to the Common Stock of Amazon.com, Inc. due June 22, 2027</B></FONT></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="padding-top: 3pt; width: 23%; border-bottom: white 1pt solid; background-color: #D9D9D6; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Agent:</B></FONT></TD>
    <TD STYLE="padding-left: 4pt; padding-top: 3pt; width: 77%; padding-bottom: 3pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Wells Fargo Securities, LLC (&ldquo;<U>WFS</U>&rdquo;).
    The agent will receive the agent discount set forth on the cover page of this pricing supplement. The agent may resell the securities
    to other securities dealers at the original offering price of the securities less a concession not in excess of $17.50 per security. Such
    securities dealers may include Wells Fargo Advisors (&ldquo;<U>WFA</U>&rdquo;) (the trade name of the retail brokerage business of WFS&rsquo;s
    affiliates, Wells Fargo Clearing Services, LLC and Wells Fargo Advisors Financial Network, LLC). In addition to the concession allowed
    to WFA, WFS may pay $0.75 per security of the agent&rsquo;s discount to WFA as a distribution expense fee for each security sold by WFA.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to the forgoing, in respect of certain securities
    sold in this offering, our affiliate, RBCCM, may pay a fee of up to $1.00 per security to selected securities dealers in consideration
    for marketing and other services in connection with the distribution of the securities to other securities dealers. We or one of our affiliates
    will also pay an expected fee to a broker-dealer that is unaffiliated with us for providing certain electronic platform services with
    respect to this offering.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">WFS and/or RBCCM, and/or one or more of their respective
    affiliates, expects to realize hedging profits projected by their proprietary pricing models to the extent they assume the risks inherent
    in hedging our obligations under the securities. If WFS or any other dealer participating in the distribution of the securities or any
    of their affiliates conducts hedging activities for us in connection with the securities, that dealer or its affiliates will expect to
    realize a profit projected by its proprietary pricing models from those hedging activities. Any such projected profit will be in addition
    to any discount, concession or fee received in connection with the sale of the securities to you.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; border-bottom: white 1pt solid; background-color: #D9D9D6; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Denominations:</B></FONT></TD>
    <TD STYLE="padding-left: 4pt; padding-top: 3pt; text-align: justify; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,000 and any integral multiple of $1,000</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; border-bottom: white 1pt solid; background-color: #D9D9D6; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CUSIP:</B></FONT></TD>
    <TD STYLE="padding-left: 4pt; padding-top: 3pt; text-align: justify; padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">78017PQ95</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">______________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">* The calculation day is subject to postponement due to
non-trading days and the occurrence of a market disruption event. In addition, the stated maturity date will be postponed if the calculation
day is postponed and will be adjusted for non-business days. For more information regarding adjustments to the calculation day and the
stated maturity date, see &ldquo;General Terms of the Securities&mdash;Consequences of a Market Disruption Event; Postponement of a Calculation
Day&mdash;Securities Linked to a Single Market Measure&rdquo; and &ldquo;&mdash;Payment Dates&rdquo; in the accompanying product supplement.
In addition, for information regarding the circumstances that may result in a market disruption event, see &ldquo;General Terms of the
Securities&mdash;Certain Terms for Securities Linked to an Underlying Stock&mdash;Market Disruption Events&rdquo; in the accompanying
product supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</B></FONT></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Principal at Risk Securities Linked to the Common Stock of Amazon.com, Inc. due June 22, 2027</B></FONT></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #5E8AB4">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Additional Information about the Issuer and the Securities</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should read this pricing supplement together with
the prospectus dated December 20, 2023, as supplemented by the prospectus supplement dated December 20, 2023, relating to our Senior Global
Medium-Term Notes, Series J, of which the securities are a part, and the product supplement no. WF1 dated December 20, 2023. <B>This pricing
supplement, together with these documents, contains the terms of the securities and supersedes all other prior or contemporaneous oral
statements as well as any other written materials, including preliminary or indicative pricing terms, correspondence, trade ideas, structures
for implementation, sample structures, fact sheets, brochures or other educational materials of ours.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have not authorized anyone to provide any information
or to make any representations other than those contained or incorporated by reference in this pricing supplement and the documents listed
below. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give
you. These documents are an offer to sell only the securities offered hereby, but only under circumstances and in jurisdictions where
it is lawful to do so. The information contained in each such document is current only as of its date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the information in this pricing supplement differs
from the information contained in the documents listed below, you should rely on the information in this pricing supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should carefully consider, among other things, the
matters set forth in &ldquo;Selected Risk Considerations&rdquo; in this pricing supplement and &ldquo;Risk Factors&rdquo; in the documents
listed below, as the securities involve risks not associated with conventional debt securities. We urge you to consult your investment,
legal, tax, accounting and other advisers before you invest in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>You may access these documents on the SEC website at
www.sec.gov as follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC website):</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Prospectus dated December 20, 2023:<BR>
</FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1000275/000119312523299520/d645671d424b3.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">https://www.sec.gov/Archives/edgar/data/1000275/000119312523299520/d645671d424b3.htm</FONT></A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Prospectus Supplement dated December 20, 2023:<BR>
</FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1000275/000119312523299523/d638227d424b3.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">https://www.sec.gov/Archives/edgar/data/1000275/000119312523299523/d638227d424b3.htm</FONT></A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Product Supplement No. WF1 dated December 20, 2023:<BR>
</FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1000275/000114036123058587/ef20016916_424b5.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">https://www.sec.gov/Archives/edgar/data/1000275/000114036123058587/ef20016916_424b5.htm</FONT></A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Central Index Key, or CIK, on the SEC website is 1000275.
As used in this pricing supplement, &ldquo;Royal Bank of Canada,&rdquo; the &ldquo;Bank,&rdquo; &ldquo;we,&rdquo; &ldquo;our&rdquo; and
&ldquo;us&rdquo; mean only Royal Bank of Canada.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</B></FONT></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Principal at Risk Securities Linked to the Common Stock of Amazon.com, Inc. due June 22, 2027</B></FONT></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #5E8AB4">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">

</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Estimated Value of the Securities</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The initial estimated value of the securities is based
on the value of our obligation to make the payments on the securities, together with the mid-market value of the derivative embedded in
the terms of the securities. Our estimate is based on a variety of assumptions, including our internal funding rate (which represents
a discount from our credit spreads), expectations as to dividends, interest rates and volatility, and the expected term of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The securities are our debt securities. As is the case
for all of our debt securities, including our structured notes, the economic terms of the securities reflect our actual or perceived creditworthiness.
In addition, because structured notes result in increased operational, funding and liability management costs to us, we typically borrow
the funds under structured notes at a rate that is lower than the rate that we might pay for a conventional fixed or floating rate debt
security of comparable maturity. The lower internal funding rate, the agent discount and the hedging-related costs relating to the securities
reduce the economic terms of the securities to you and result in the initial estimated value for the securities being less than their
original issue price. Unlike the initial estimated value, any value of the securities determined for purposes of a secondary market transaction
may be based on a secondary market rate, which may result in a lower value for the securities than if our initial internal funding rate
were used.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to satisfy our payment obligations under the
securities, we may choose to enter into certain hedging arrangements (which may include call options, put options or other derivatives)
with the agent, RBCCM and/or one of their respective affiliates. The terms of these hedging arrangements may take into account a number
of factors, including our creditworthiness, interest rate movements, volatility and the tenor of the securities. The economic terms of
the securities and the initial estimated value depend in part on the terms of these hedging arrangements. Our cost of hedging will include
the projected profit that we or our counterparty(ies) expect to realize in consideration for assuming the risks inherent in hedging our
obligations under the securities. Because hedging our obligations entails risks and may be influenced by market forces beyond our or our
counterparty(ies)&rsquo; control, such hedging may result in a profit that is more or less than expected, or could result in a loss.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See &ldquo;Selected Risk Considerations&mdash;Risks Relating
To The Estimated Value Of The Securities And Any Secondary Market&mdash;The Initial Estimated Value Of The Securities Is Less Than The
Original Offering Price&rdquo; below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any price that the agent or RBCCM makes available from
time to time after the original issue date at which it would be willing to purchase the securities will generally reflect the agent&rsquo;s
or RBCCM&rsquo;s estimate of their value, as applicable, less a customary bid-ask spread for similar trades and the cost of unwinding
any related hedge transactions. That estimated value will be based upon a variety of factors, including then prevailing market conditions
and our creditworthiness. However, for a period of three months after the original issue date, the price at which the agent or RBCCM may
purchase the securities is expected to be higher than the price that would be determined based on the agent&rsquo;s or RBCCM&rsquo;s valuation,
respectively, at that time less the bid-ask spread and hedging unwind costs referenced above. This is because, at the beginning of this
period, that price will not include certain costs that were included in the original offering price, particularly a portion of the agent
discount and commission (not including the selling concession) and the expected profits that we or our hedging counterparty(ies) expect
to receive from our hedging transactions. As the period continues, these costs are expected to be gradually included in the price that
the agent or RBCCM would be willing to pay, and the difference between that price and the price that would be determined based on the
agent&rsquo;s or RBCCM&rsquo;s valuation of the securities, as applicable, less a bid-ask spread and hedging unwind costs will decrease
over time until the end of this period. After this period, if the agent or RBCCM continues to make a market in the securities, the prices
that it would pay for them are expected to reflect the agent&rsquo;s or RBCCM&rsquo;s estimated value, respectively, less the bid-ask
spread and hedging unwind costs referenced above. In addition, the value of the securities shown on your account statement will generally
reflect the price that the agent or RBCCM, as applicable, would be willing to pay to purchase the securities at that time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</B></FONT></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Principal at Risk Securities Linked to the Common Stock of Amazon.com, Inc. due June 22, 2027</B></FONT></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #5E8AB4">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">


</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Investor Considerations</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The securities are not appropriate for all investors.
The securities may be an appropriate investment for investors who:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#9642;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">seek a contingent fixed return at maturity of 26.00%
of the face amount if the ending value is greater than or equal to the threshold value;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#9642;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">are willing to accept the risk that, if the ending value
is less than the threshold value, they will have full downside exposure to the decrease in the value of the Underlying Stock from the
starting value, and they will lose more than 15%, and possibly all, of the face amount of their securities at maturity;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#9642;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">are willing to accept that any positive return they will
receive at maturity will be limited to the contingent fixed return, regardless of the extent to which the ending value exceeds the starting
value;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#9642;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">understand and are willing to accept the full downside
risk of the Underlying Stock;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#9642;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">are willing to forgo interest payments on the securities
and dividends on the Underlying Stock; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#9642;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">are willing to hold the securities until maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The securities may not be an appropriate investment
for investors who:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#9642;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">seek a liquid investment or are unable or unwilling to
hold the securities to maturity;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#9642;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">seek full exposure to the upside performance of the Underlying
Stock;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#9642;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">seek a greater contingent fixed return at maturity than
will be provided by the terms of the securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#9642;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">require full payment of the face amount of the securities
at stated maturity;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#9642;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">are unwilling to purchase securities with an estimated
value as of the pricing date that is lower than the original offering price and that may be as low as the lower estimated value set forth
on the cover page;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#9642;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">are unwilling to accept the risk that the ending value
may be less than the threshold value;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#9642;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">seek current income over the term of the securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#9642;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">are unwilling to accept the risk of exposure to the Underlying
Stock;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#9642;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">seek exposure to the Underlying Stock but are unwilling
to accept the risk/return trade-offs inherent in the maturity payment amount for the securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#9642;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">are unwilling to accept the credit risk of Royal Bank
of Canada to obtain exposure to the Underlying Stock; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#9642;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">prefer the lower risk of fixed income investments with
comparable maturities issued by companies with comparable credit ratings.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>The considerations identified above are not exhaustive. Whether or not the
securities are an appropriate investment for you will depend on your individual circumstances, and you should reach an investment decision
only after you and your investment, legal, tax, accounting and other advisors have carefully considered the appropriateness of an investment
in the securities in light of your particular circumstances. You should also review carefully the &ldquo;Selected Risk Considerations&rdquo;
herein and the &ldquo;Risk Factors&rdquo; in the accompanying product supplement for risks related to an investment in the securities.
For more information about the Underlying Stock, see the section titled &ldquo;Information about the Underlying Stock&rdquo; below.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</B></FONT></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Principal at Risk Securities Linked to the Common Stock of Amazon.com, Inc. due June 22, 2027</B></FONT></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #5E8AB4">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Determining Payment at Stated Maturity</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;On the stated maturity date, you will receive a
cash payment per security (the maturity payment amount) calculated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_004.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</B></FONT></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Principal at Risk Securities Linked to the Common Stock of Amazon.com, Inc. due June 22, 2027</B></FONT></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: #5E8AB4; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Selected Risk Considerations</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An investment in the securities involves significant risks.
We urge you to consult your investment, legal, tax, accounting and other advisers before you invest in the securities. Some of the risks
that apply to an investment in the securities are summarized below, but we urge you to read also the &ldquo;Risk Factors&rdquo; sections
of the accompanying prospectus, prospectus supplement and product supplement. You should not purchase the securities unless you understand
and can bear the risks of investing in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Risks Relating To The Terms And Structure Of The
Securities</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If The Ending Value Is Less Than The Threshold Value,
You May Lose Some Or All Of The Face Amount Of Your Securities At Maturity.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will not repay you a fixed amount on the securities
on the stated maturity date. The maturity payment amount will depend on the direction of and percentage change in the ending value relative
to the starting value and the other terms of the securities. Because the value of the Underlying Stock will be subject to market fluctuations,
the maturity payment amount may be more or less, and possibly significantly less, than the face amount of your securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the ending value is less than the threshold value,
the maturity payment amount will be less than the face amount and you will have full downside exposure to the decrease in the value of
the Underlying Stock from the starting value. The threshold value is 85% of the starting value. For example, if the Underlying Stock has
declined by 15.1% from the starting value to the ending value, you will not receive any benefit of the contingent downside protection
feature and you will lose 15.1% of the face amount. As a result, you will not receive any contingent downside protection if the value
of the Underlying Stock declines below the threshold value, and you will lose more than 15%, and possibly all, of the face amount of your
securities at maturity. This will be the case even if the value of the Underlying Stock is greater than or equal to the starting value
or the threshold value at certain times during the term of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Even if the ending value is greater than the starting
value, your yield on the securities may be less than the yield you would earn if you bought a traditional interest-bearing debt security
of Royal Bank of Canada or another issuer with a similar credit rating with the same stated maturity date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>You Will Receive The Contingent Fixed Return Only If
The Ending Value Is Greater Than Or Equal To The Threshold Value.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You will receive the contingent fixed return only if the
ending value is greater than or equal to the threshold value. If the ending value is less than the threshold value, then you will not
receive the contingent fixed return.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Your Return Will Be Limited To The Contingent Fixed
Return And May Be Lower Than The Return On A Direct Investment In The Underlying Stock.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The opportunity to participate in the possible increases
in the value of the Underlying Stock through an investment in the securities will be limited because any positive return on the securities
will not exceed the contingent fixed return, regardless of any increase in the value of the Underlying Stock, which may be significant.
Therefore, your return on the securities may be lower than the return on a direct investment in the Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Securities Do Not Pay Interest, And Your Return
On The Securities May Be Lower Than The Return On A Conventional Debt Security Of Comparable Maturity.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There will be no periodic interest payments on the securities
as there would be on a conventional fixed-rate or floating-rate debt security having the same maturity. The return that you will receive
on the securities, which could be negative, may be less than the return you could earn on other investments. Even if your return is positive,
your return may be less than the return you would earn if you purchased one of our conventional senior interest-bearing debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Payments On The Securities Are Subject To Our Credit
Risk, And Market Perceptions About Our Creditworthiness May Adversely Affect The Market Value Of The Securities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The securities are our senior unsecured debt securities,
and your receipt of any amounts due on the securities is dependent upon our ability to pay our obligations as they come due. If we were
to default on our payment obligations, you may not receive any amounts owed to you under the securities and you could lose your entire
investment. In addition, any negative changes in market perceptions about our creditworthiness may adversely affect the market value of
the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The U.S. Federal Income Tax Consequences Of An Investment
In The Securities Are Uncertain.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is no direct legal authority regarding the proper
U.S. federal income tax treatment of the securities, and significant aspects of the tax treatment of the securities are uncertain. You
should review carefully the section entitled &ldquo;United States Federal Income Tax Considerations&rdquo; herein, in combination with
the section entitled &ldquo;United States Federal Tax Considerations&rdquo; in the accompanying product supplement, and consult your tax
adviser regarding the U.S. federal income tax consequences of an investment in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</B></FONT></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Principal at Risk Securities Linked to the Common Stock of Amazon.com, Inc. due June 22, 2027</B></FONT></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-style: normal"><B><U>Risks Relating
To The Estimated Value Of The Securities And Any Secondary Market</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>There May Not Be An Active Trading Market For The Securities
And Sales In The Secondary Market May Result In Significant Losses.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There may be little or no secondary market for the securities.
The securities will not be listed on any securities exchange. Either (a) the agent and/or its affiliates or (b) RBCCM and our other affiliates
may make a market for the securities; however, they are not required to do so and, if they choose to do so, may stop any market-making
activities at any time. Because other dealers are not likely to make a secondary market for the securities, the price at which you may
be able to trade your securities is likely to depend on the price, if any, at which the agent, RBCCM or any of their respective affiliates,
as applicable, is willing to buy the securities. At this time, we do not expect both the agent (and/or its affiliates) and RBCCM (and
our other affiliates) to attempt to make a market for the securities at the same time. The agent&rsquo;s and RBCCM&rsquo;s valuations
of the securities may differ, and consequently the price at which you may be able to sell the securities, if at all, may differ (and may
be lower) depending on whether the agent or RBCCM is purchasing securities at that time. Even if a secondary market for the securities
develops, it may not provide enough liquidity to allow you to easily trade or sell the securities. We expect that transaction costs in
any secondary market would be high. As a result, the difference between bid and ask prices for your securities in any secondary market
could be substantial. If you sell your securities before maturity, you may have to do so at a substantial discount from the price that
you paid for them, and as a result, you may suffer significant losses. The securities are not designed to be short-term trading instruments.
Accordingly, you should be able and willing to hold your securities to maturity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Initial Estimated Value Of The Securities Is Less
Than The Original Offering Price.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The initial estimated value of the securities is less
than the original offering price of the securities and does not represent a minimum price at which we, RBCCM or any of our other affiliates
would be willing to purchase the securities in any secondary market (if any exists) at any time. If you attempt to sell the securities
prior to maturity, their market value may be lower than the price you paid for them and the initial estimated value. This is due to, among
other things, changes in the value of the Underlying Stock, the internal funding rate we pay to issue securities of this kind (which is
lower than the rate at which we borrow funds by issuing conventional fixed rate debt) and the inclusion in the original offering price
of the agent discount, our or our hedge counterparty(ies)&rsquo; estimated profit and the estimated costs related to our hedging of the
securities. These factors, together with various credit, market and economic factors over the term of the securities, are expected to
reduce the price at which you may be able to sell the securities in any secondary market and will affect the value of the securities in
complex and unpredictable ways.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assuming no change in market conditions or any other relevant
factors, the price, if any, at which you may be able to sell your securities prior to maturity may be less than your original purchase
price, as any such sale price would not be expected to include the agent discount, our or our hedge counterparty(ies)&rsquo; estimated
profit or the hedging costs relating to the securities. In addition, any price at which you may sell the securities is likely to reflect
customary bid-ask spreads for similar trades. In addition to bid-ask spreads, the value of the securities determined for any secondary
market price is expected to be based on a secondary market rate rather than the internal funding rate used to price the securities and
determine the initial estimated value. As a result, the secondary market price will be less than if the internal funding rate was used.
Moreover, if the agent is making a market for the securities, any secondary market price will be based on the agent&rsquo;s valuation
of the securities, which may differ from (and may be lower than) the valuation that we would determine for the securities at that time
based on the methodology by which we determined the initial estimated value range set forth on the cover page of this pricing supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For a limited period of time after the original issue
date, the agent or RBCCM may purchase the securities at a price that is greater than the price that would otherwise be determined at that
time as described in the preceding paragraph. However, over the course of that period, assuming no changes in any other relevant factors,
the price you may receive if you sell your securities is expected to decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Initial Estimated Value Of The Securities Is Only
An Estimate, Calculated As Of The Time The Terms Of The Securities Are Set.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The initial estimated value of the securities is based
on the value of our obligation to make the payments on the securities, together with the mid-market value of the derivative embedded in
the terms of the securities. Our estimate is based on a variety of assumptions, including our internal funding rate (which represents
a discount from our credit spreads), expectations as to dividends on the Underlying Stock, interest rates and volatility, and the expected
term of the securities. These assumptions are based on certain forecasts about future events, which may prove to be incorrect. Other entities,
including the agent in connection with determining any secondary market price for the securities, may value the securities or similar
securities at a price that is significantly different than we do.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The value of the securities at any time after the pricing
date will vary based on many factors, including changes in market conditions, and cannot be predicted with accuracy. As a result, the
actual value you would receive if you sold the securities in any secondary market, if any, should be expected to differ materially from
the initial estimated value of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Value Of The Securities Prior To Stated Maturity
Will Be Affected By Numerous Factors, Some Of Which Are Related In Complex Ways.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The value of the securities prior to stated maturity will
be affected by the then-current value of the Underlying Stock, interest rates at that time and a number of other factors, some of which
are interrelated in complex ways. The effect of any one factor may be offset or magnified</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</B></FONT></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Principal at Risk Securities Linked to the Common Stock of Amazon.com, Inc. due June 22, 2027</B></FONT></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">by the effect of another factor. The following factors,
which we refer to as the &ldquo;<U>derivative component factors</U>,&rdquo; and which are described in more detail in the accompanying
product supplement, are expected to affect the value of the securities: performance of the Underlying Stock; interest rates; volatility
of the Underlying Stock; time remaining to maturity; and dividend yields on the Underlying Stock. When we refer to the &ldquo;<U>value</U>&rdquo;
of your security, we mean the value you could receive for your security if you are able to sell it in the open market before the stated
maturity date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to the derivative component factors, the value
of the securities will be affected by actual or anticipated changes in our creditworthiness. You should understand that the impact of
one of the factors specified above, such as a change in interest rates, may offset some or all of any change in the value of the securities
attributable to another factor, such as a change in the value of the Underlying Stock. Because numerous factors are expected to affect
the value of the securities, changes in the value of the Underlying Stock may not result in a comparable change in the value of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Risks Relating To Conflicts Of Interest</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our Economic Interests And Those Of Any Dealer Participating
In The Offering Are Potentially Adverse To Your Interests.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should be aware of the following ways in which our
economic interests and those of any dealer participating in the distribution of the securities, which we refer to as a &ldquo;<U>participating
dealer</U>,&rdquo; are potentially adverse to your interests as an investor in the securities. In engaging in certain of the activities
described below and as discussed in more detail in the accompanying product supplement, our affiliates or any participating dealer or
its affiliates may take actions that may adversely affect the value of and your return on the securities, and in so doing they will have
no obligation to consider your interests as an investor in the securities. Our affiliates or any participating dealer or its affiliates
may realize a profit from these activities even if investors do not receive a favorable investment return on the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The calculation agent is our affiliate and may
be required to make discretionary judgments that affect the return you receive on the securities.</I></B> RBCCM, which is our affiliate,
will be the calculation agent for the securities. As calculation agent, RBCCM will determine any values of the Underlying Stock and make
any other determinations necessary to calculate any payments on the securities. In making these determinations, RBCCM may be required
to make discretionary judgments that may adversely affect any payments on the securities. See the sections entitled &ldquo;General Terms
of the Securities&mdash; Certain Terms for Securities Linked to an Underlying Stock&mdash;Market Disruption Events&rdquo; and &ldquo;&mdash;Adjustment
Events&rdquo; in the accompanying product supplement. In making these discretionary judgments, the fact that RBCCM is our affiliate may
cause it to have economic interests that are adverse to your interests as an investor in the securities, and RBCCM&rsquo;s determinations
as calculation agent may adversely affect your return on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The estimated value of the securities was calculated
by us and is therefore not an independent third-party valuation.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Research reports by our affiliates or any participating
dealer or its affiliates may be inconsistent with an investment in the securities and may adversely affect the value of the Underlying
Stock.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Business activities of our affiliates or any participating
dealer or its affiliates with the Underlying Stock issuer may adversely affect the value of the Underlying Stock.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Hedging activities by our affiliates or any participating
dealer or its affiliates may adversely affect the value of the Underlying Stock.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Trading activities by our affiliates or any participating
dealer or its affiliates may adversely affect the value of the Underlying Stock.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>A participating dealer or its affiliates may realize
hedging profits projected by its proprietary pricing models in addition to any selling concession and/or fee, creating a further incentive
for the participating dealer to sell the securities to you.</I></B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Risks Relating To The Underlying Stock</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Maturity Payment Amount Will Depend Upon The Performance
Of The Underlying Stock And Therefore The Securities Are Subject To The Following Risks, Each As Discussed In More Detail In The Accompanying
Product Supplement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Investing In The Securities Is Not The Same As Investing
In The Underlying Stock. </B>Investing in the securities is not equivalent to investing in the Underlying Stock. As an investor in the
securities, your return will not reflect the return you would realize if you actually owned and held the Underlying Stock for a period
similar to the term of the securities because you will not receive any dividend payments, distributions or any other payments paid on
the Underlying Stock. As a holder of the securities, you will not have any voting rights or any other rights that holders of the Underlying
Stock would have.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Historical Values Of The Underlying Stock Should Not
Be Taken As An Indication Of Its Future Performance During The Term Of The Securities.</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</B></FONT></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Principal at Risk Securities Linked to the Common Stock of Amazon.com, Inc. due June 22, 2027</B></FONT></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Securities May Become Linked To The Common Stock
Of A Company Other Than The Original Underlying Stock Issuer.</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>We Cannot Control Actions By The Underlying Stock
Issuer.</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>We And Our Affiliates Have No Affiliation With The
Underlying Stock Issuer And Have Not Independently Verified Its Public Disclosure Of Information.</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>You Have Limited Anti-dilution Protection.</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</B></FONT></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Principal at Risk Securities Linked to the Common Stock of Amazon.com, Inc. due June 22, 2027</B></FONT></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: #5E8AB4; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">


</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Hypothetical Examples and Returns</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The payout profile, return table and examples below
illustrate hypothetical maturity payment amounts for a $1,000 face amount security on a hypothetical offering of securities under various
scenarios, with the assumptions set forth in the table below. The terms used for purposes of these hypothetical examples do not represent
the actual starting value or threshold value. The hypothetical starting value of $100.00 has been chosen for illustrative purposes only
and does not represent the actual starting value. The actual starting value and threshold value are set forth under &ldquo;Terms of the
Securities&rdquo; above. For historical data regarding the actual closing prices of the Underlying Stock, see the historical information
provided below. The payout profile, return table and examples below assume that an investor purchases the securities for $1,000 per security.
These examples are for purposes of illustration only and the values used in the examples may have been rounded for ease of analysis. The
actual maturity payment amount and the resulting pre-tax total rate of return will depend on the actual terms of the securities.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 77%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2pt 3pt; width: 36%; border: Black 1pt solid; font: 10pt Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Contingent Fixed Return:</B></FONT></TD>
    <TD STYLE="padding: 2pt 3pt; width: 64%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">26.00% of the face amount per security or $260.00 per security</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2pt 3pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Hypothetical Starting Value:</B></FONT></TD>
    <TD STYLE="padding: 2pt 3pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">$100.00</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2pt 3pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Hypothetical Threshold Value:</B></FONT></TD>
    <TD STYLE="padding: 2pt 3pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">$85.00 (85% of the hypothetical starting value)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical Payout Profile</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_005.jpg" ALT=""></P>

<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</B></FONT></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Principal at Risk Securities Linked to the Common Stock of Amazon.com, Inc. due June 22, 2027</B></FONT></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Hypothetical Returns</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 95%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; width: 25%; border-bottom: #688FCF 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Hypothetical</B>&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>ending value</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P></TD>
    <TD STYLE="width: 25%; border-bottom: #688FCF 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Hypothetical</B>&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>stock return</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P></TD>
    <TD STYLE="width: 25%; border-bottom: #688FCF 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Hypothetical</B>&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>maturity payment amount per security</B>&nbsp;</P></TD>
    <TD STYLE="width: 25%; border-bottom: #688FCF 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Hypothetical</B>&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>pre-tax total</B>&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>rate of return<SUP>(1)</SUP></B>&nbsp;</P></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$200.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">100.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,260.00</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">26.00%</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$175.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">75.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,260.00</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">26.00%</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$150.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">50.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,260.00</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">26.00%</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$140.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">40.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,260.00</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">26.00%</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$130.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">30.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,260.00</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">26.00%</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$126.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">26.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,260.00</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">26.00%</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$120.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">20.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,260.00</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">26.00%</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$110.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">10.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,260.00</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">26.00%</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$100.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,260.00</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">26.00%</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$95.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-5.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,260.00</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">26.00%</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$90.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-10.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,260.00</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">26.00%</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$85.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-15.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,260.00</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">26.00%</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$84.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-16.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$840.00</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-16.00%</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$80.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-20.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$800.00</FONT></TD>
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-20.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$70.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-30.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$700.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-30.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$60.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-40.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$600.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-40.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$50.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-50.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$500.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-50.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$25.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-75.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$250.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-75.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$0.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-100.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$0.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-100.00%</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 24.5pt"><SUP>(1)</SUP></TD><TD STYLE="text-align: justify">The hypothetical pre-tax total rate of return is the number, expressed as a percentage, that results from
comparing the maturity payment amount per security to the face amount of $1,000.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</B></FONT></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Principal at Risk Securities Linked to the Common Stock of Amazon.com, Inc. due June 22, 2027</B></FONT></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical Examples</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 1. The ending value is greater than the threshold
value, and the maturity payment amount is greater than the face amount and reflects a return equal to the contingent fixed return, which
is greater than the stock return:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 66%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 68%; border-bottom: white 1pt solid; border-right: white 1pt solid; font-family: Calibri, Helvetica, Sans-Serif">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 32%; border-bottom: white 1pt solid; border-right: white 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Underlying Stock</B></FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; font-family: Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical starting value:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$100.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; font-family: Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical ending value:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$90.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; font-family: Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical threshold value:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$85.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical stock return</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(ending value &ndash; starting value)/starting value:</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-10.00%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hyphetical ending value is greater than
the hypothetical threshold value, the maturity payment amount per security would be equal to the face amount of $1,000 <I>plus</I> the
contingent fixed return.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date you would receive $1,260.00
per security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 2. The ending value is greater than the threshold
value, and the maturity payment amount is greater than the face amount and reflects a return equal to the contingent fixed return, which
is less than the stock return:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 66%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 68%; border-bottom: white 1pt solid; border-right: white 1pt solid; font-family: Calibri, Helvetica, Sans-Serif">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 32%; border-bottom: white 1pt solid; border-right: white 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Underlying Stock</B></FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; font-family: Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical starting value:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$100.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; font-family: Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical ending value:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$150.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; font-family: Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical threshold value:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$85.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical stock return </B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(ending value &ndash; starting value)/starting value:</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.00%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hypothetical ending value is greater than
the hypothetical threshold value, the maturity payment amount per security would be equal to the face amount of $1,000 <I>plus</I> the
contingent fixed return. Even though the Underlying Stock increased by 50% from the starting value to the ending value in this example,
your return is limited to the contingent fixed return of 26.00%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date you would receive $1,260.00
per security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 3. The ending value is less than the threshold
value, and the maturity payment amount is less than the face amount: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 66%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 68%; border-bottom: white 1pt solid; border-right: white 1pt solid; font-family: Calibri, Helvetica, Sans-Serif">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 32%; border-bottom: white 1pt solid; border-right: white 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Underlying Stock</B></FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; font-family: Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical starting value:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$100.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; font-family: Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical ending value:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$50.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; font-family: Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical threshold value:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$85.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical stock return</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(ending value &ndash; starting value)/starting value:</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-50.00%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hypothetical ending value is less than the
hypothetical threshold value, you would lose a portion of the face amount of your securities and receive a maturity payment amount per
security equal to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.75pt; text-align: center; text-indent: -10.35pt">$1,000 + ($1,000 &times;
stock return)&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.75pt; text-align: center; text-indent: -10.35pt">= $1,000 + ($1,000 &times;
-50.00%) = $500.00</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.75pt; text-align: center; text-indent: -10.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date you would receive $500.00
per security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If the ending value is less than the threshold value,
you will have full downside exposure to the decrease in the value of the Underlying Stock from the starting value, and you will lose more
than 15%, and possibly all, of the face amount of your securities at maturity.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</B></FONT></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Principal at Risk Securities Linked to the Common Stock of Amazon.com, Inc. due June 22, 2027</B></FONT></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: #5E8AB4; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">

</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Information about the Underlying Stock</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Underlying Stock is registered under the Securities
Exchange Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;). Companies with securities registered under the Exchange Act
are required to file financial and other information specified by the SEC periodically. Information provided to or filed with the SEC
by the issuer of the Underlying Stock can be located on a website maintained by the SEC at https://www.sec.gov by reference to that issuer&rsquo;s
SEC file number provided below. Information from outside sources is not incorporated by reference in, and should not be considered part
of, this pricing supplement. We have not independently verified the accuracy or completeness of the information contained in outside sources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to publicly available information, Amazon.com,
Inc. serves consumers through its online and physical stores; manufactures and sells electronic devices; develops and produces media content;
offers subscription services; offers programs that enable sellers to sell their products in its stores and to fulfill orders using its
services; offers developers and enterprises a set of technology services, including compute, storage, database, analytics and machine
learning and other services; offers programs that allow authors, independent publishers, musicians, filmmakers, Twitch streamers, skill
and app developers and others to publish and sell content; and provides advertising services to sellers, vendors, publishers, authors
and others, through programs such as sponsored ads, display and video advertising.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The issuer of the Underlying Stock&rsquo;s SEC file number
is 000-22513. The Underlying Stock is listed on The Nasdaq Stock Market under the ticker symbol &ldquo;AMZN.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Historical Information </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We obtained the closing prices of the Underlying Stock
in the graph below from Bloomberg Finance L.P., without independent verification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following graph sets forth daily closing prices of
the Underlying Stock for the period from January 1, 2015 to December 17, 2025. The closing price of the Underlying Stock on December 17,
2025 was $221.27. The red line represents the threshold value. The historical performance of the Underlying Stock should not be taken
as an indication of the future performance of the Underlying Stock during the term of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_007.gif" ALT="" STYLE="height: 352px; width: 553px"></P>

<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</B></FONT></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Principal at Risk Securities Linked to the Common Stock of Amazon.com, Inc. due June 22, 2027</B></FONT></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: #5E8AB4; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>United States Federal Income Tax Considerations</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should review carefully the section in the accompanying
product supplement entitled &ldquo;United States Federal Tax Considerations.&rdquo; The following discussion, when read in combination
with that section, constitutes the full opinion of our counsel, Davis Polk &amp; Wardwell LLP, regarding the material U.S. federal income
tax consequences of owning and disposing of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally, this discussion assumes that you purchased
the securities for cash in the original issuance at the stated issue price and does not address other circumstances specific to you, including
consequences that may arise due to any other investments relating to the Underlying Stock. You should consult your tax adviser regarding
the effect any such circumstances may have on the U.S. federal income tax consequences of your ownership of a security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of our counsel, it is reasonable to treat
the securities for U.S. federal income tax purposes as prepaid derivative contracts that are &ldquo;open transactions,&rdquo; as described
in the section entitled &ldquo;United States Federal Tax Considerations&mdash;Tax Consequences to U.S. Holders&mdash;Securities Treated
as Prepaid Derivative Contracts that are Open Transactions&rdquo; in the accompanying product supplement. There is uncertainty regarding
this treatment, and the Internal Revenue Service (the &ldquo;IRS&rdquo;) or a court might not agree with it. A different tax treatment
could be adverse to you. Generally, if this treatment is respected, (i) you should not recognize taxable income or loss prior to the taxable
disposition of your securities (including upon maturity or an earlier redemption, if applicable) and (ii) the gain or loss on your securities
should be treated as short-term capital gain or loss unless you have held the securities for more than one year, in which case your gain
or loss should be treated as long-term capital gain or loss.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not plan to request a ruling from the IRS regarding
the treatment of the securities. An alternative characterization of the securities could materially and adversely affect the tax consequences
of ownership and disposition of the securities, including the timing and character of income recognized. In addition, the U.S. Treasury
Department and the IRS have requested comments on various issues regarding the U.S. federal income tax treatment of &ldquo;prepaid forward
contracts&rdquo; and similar financial instruments and have indicated that such transactions may be the subject of future regulations
or other guidance. Furthermore, members of Congress have proposed legislative changes to the tax treatment of derivative contracts. Any
legislation, Treasury regulations or other guidance promulgated after consideration of these issues could materially and adversely affect
the tax consequences of an investment in the securities, possibly with retroactive effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-U.S. holders. As discussed under &ldquo;United States
Federal Tax Considerations&mdash;Tax Consequences to Non-U.S. Holders&mdash;Dividend Equivalents under Section 871(m) of the Code&rdquo;
in the accompanying product supplement, Section 871(m) of the Internal Revenue Code and Treasury regulations promulgated thereunder (&ldquo;Section
871(m)&rdquo;) generally impose a 30% withholding tax on dividend equivalents paid or deemed paid to non-U.S. holders with respect to
certain financial instruments linked to U.S. equities or indices that include U.S. equities. The Treasury regulations, as modified by
an IRS notice, exempt financial instruments issued prior to January 1, 2027 that do not have a &ldquo;delta&rdquo; of one. Based on certain
determinations made by us, our counsel is of the opinion that Section 871(m) should not apply to the securities with regard to non-U.S.
holders. Our determination is not binding on the IRS, and the IRS may disagree with this determination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will not be required to pay any additional amounts
with respect to U.S. federal withholding taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should consult your tax adviser regarding the U.S.
federal income tax consequences of an investment in the securities, including possible alternative treatments, as well as tax consequences
arising under the laws of any state, local or non-U.S. taxing jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</B></FONT></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Principal at Risk Securities Linked to the Common Stock of Amazon.com, Inc. due June 22, 2027</B></FONT></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: #5E8AB4; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Supplemental Benefit Plan Investor Considerations</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The securities are contractual financial instruments.
The financial exposure provided by the securities is not a substitute or proxy for, and is not intended as a substitute or proxy for,
individualized investment management or advice for the benefit of any purchaser or holder of the securities. The securities have not been
designed and will not be administered in a manner intended to reflect the individualized needs and objectives of any purchaser or holder
of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each purchaser or holder of any securities acknowledges
and agrees that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the purchaser or holder or its fiduciary has made and
shall make all investment decisions for the purchaser or holder and the purchaser or holder has not relied and shall not rely in any way
upon us or any of our affiliates to act as a fiduciary or adviser of the purchaser or holder with respect to (i) the design and terms
of the securities, (ii) the purchaser or holder&rsquo;s investment in the securities, (iii) the holding of the securities or (iv) the
exercise of or failure to exercise any rights we or any of our affiliates, or the purchaser or holder, has under or with respect to the
securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">we and our affiliates have acted and will act solely
for our own account in connection with (i) all transactions relating to the securities and (ii) all hedging transactions in connection
with our or our affiliates&rsquo; obligations under the securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">any and all assets and positions relating to hedging
transactions by us or any of our affiliates are assets and positions of those entities and are not assets and positions held for the benefit
of the purchaser or holder;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our interests and the interests of our affiliates are
adverse to the interests of the purchaser or holder; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">neither we nor any of our affiliates is a fiduciary or
adviser of the purchaser or holder in connection with any such assets, positions or transactions, and any information that we or any of
our affiliates may provide is not intended to be impartial investment advice.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Calibri, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See &ldquo;Benefit Plan Investor Considerations&rdquo;
in the accompanying prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</B></FONT></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Principal at Risk Securities Linked to the Common Stock of Amazon.com, Inc. due June 22, 2027</B></FONT></P><P STYLE="font: 11pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #5E8AB4">
    <TD STYLE="width: 100%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Validity of the Securities</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of Norton Rose Fulbright Canada LLP, as
Canadian counsel to the Bank, the issue and sale of the securities has been duly authorized by all necessary corporate action of the Bank
in conformity with the indenture, and when the securities have been duly executed, authenticated and issued in accordance with the indenture
and delivered against payment therefor, the securities will be validly issued and, to the extent validity of the securities is a matter
governed by the laws of the Province of Ontario or Qu&eacute;bec, or the federal laws of Canada applicable therein, will be valid obligations
of the Bank, subject to the following limitations: (i) the enforceability of the indenture may be limited by the Canada Deposit Insurance
Corporation Act (Canada), the Winding-up and Restructuring Act (Canada) and bankruptcy, insolvency, reorganization, receivership, moratorium,
arrangement or winding-up laws or other similar laws of general application affecting the enforcement of creditors&rsquo; rights generally;
(ii) the enforceability of the indenture is subject to general equitable principles, including the principle that the availability of
equitable remedies, such as specific performance and injunction, may only be granted at the discretion of a court of competent jurisdiction;
(iii) under applicable limitations statutes generally, including that the enforceability of the indenture will be subject to the limitations
contained in the Limitations Act, 2002 (Ontario), and such counsel expresses no opinion as to whether a court may find any provision of
the indenture to be unenforceable as an attempt to vary or exclude a limitation period under such applicable limitations statutes; (iv)
rights to indemnity and contribution under the securities or the indenture which may be limited by applicable law; and (v) courts in Canada
are precluded from giving a judgment in any currency other than the lawful money of Canada and such judgment may be based on a rate of
exchange in existence on a day other than the day of payment, as prescribed by the Currency Act (Canada). This opinion is given as of
the date hereof and is limited to the laws of the Provinces of Ontario and Qu&eacute;bec and the federal laws of Canada applicable therein.
In addition, this opinion is subject to customary assumptions about the trustee&rsquo;s authorization, execution and delivery of the indenture
and the genuineness of signatures and to such counsel&rsquo;s reliance on the Bank and other sources as to certain factual matters, all
as stated in the opinion letter of such counsel dated December 20, 2023, which has been filed as Exhibit 5.3 to the Bank&rsquo;s Form
6-K filed with the SEC dated December 20, 2023. References to the &ldquo;indenture&rdquo; in this paragraph mean the Indenture as defined
in the opinion of Norton Rose Fulbright Canada LLP dated December 20, 2023, as further amended and supplemented by the sixth supplemental
indenture dated as of July 23, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of Davis Polk &amp; Wardwell LLP, as special
United States products counsel to the Bank, when the securities offered by this pricing supplement have been issued by the Bank pursuant
to the indenture, the trustee has made, in accordance with the indenture, the appropriate notation to the master note evidencing such
securities (the &ldquo;master note&rdquo;), and such securities have been delivered against payment as contemplated herein, such securities
will be valid and binding obligations of the Bank, enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency
and similar laws affecting creditors&rsquo; rights generally, concepts of reasonableness and equitable principles of general applicability
(including, without limitation, concepts of good faith, fair dealing and the lack of bad faith) and possible judicial or regulatory actions
or applications giving effect to governmental actions or foreign laws affecting creditors&rsquo; rights, <I>provided </I>that such counsel
expresses no opinion as to (i) the enforceability of any waiver of rights under any usury or stay law or (ii) the effect of fraudulent
conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed above. This opinion is given as of
the date hereof and is limited to the laws of the State of New York. Insofar as the foregoing opinion involves matters governed by the
laws of the Provinces of Ontario and Qu&eacute;bec and the federal laws of Canada, you have received, and we understand that you are relying
upon, the opinion of Norton Rose Fulbright Canada LLP, Canadian counsel for the Bank, set forth above. In addition, this opinion is subject
to customary assumptions about the trustee&rsquo;s authorization, execution and delivery of the indenture and the authentication of the
master note and the validity, binding nature and enforceability of the indenture with respect to the trustee, all as stated in the opinion
of Davis Polk &amp; Wardwell LLP dated May 16, 2024, which has been filed as an exhibit to the Bank&rsquo;s Form 6-K filed with the SEC
on May 16, 2024. References to the &ldquo;indenture&rdquo; in this paragraph mean the Indenture as defined in the opinion of Davis Polk
&amp; Wardwell LLP dated May 16, 2024, as further amended and supplemented by the sixth supplemental indenture dated as of July 23, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: #5E8AB4; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Terms
    Incorporated in the Master Note</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All terms of the securities included in this pricing supplement
and the relevant terms included in the section entitled &ldquo;General Terms of The Securities&rdquo; in the accompanying product supplement,
as modified by this pricing supplement, if applicable, are incorporated into the master note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>dp238986_exfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024-2025 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FC.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.2b -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: cd97fb10c5efa7ad383a3a11a2e338ba -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
<head>
  <title>Filing Fee Exhibit</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="fee_001">424B2</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="fee_002">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="fee_003">0001000275</ix:nonNumeric>
      <ix:nonNumeric name="ffd:RegnFileNb" contextRef="c_report" id="fee_004">333-275898</ix:nonNumeric>
      <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="c_report" id="fee_005">N/A</ix:nonNumeric>
      <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="c_report" id="fee_006">N/A</ix:nonNumeric>
      <ix:nonNumeric name="ffd:CombinedProspectusTableNa" contextRef="c_report" id="fee_007">N/A</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000275</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-12-19</xbrli:startDate>
          <xbrli:endDate>2025-12-19</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: right">Ex-Filing Fees</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center">CALCULATION OF FILING FEE TABLES</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="fee_008">F-3</ix:nonNumeric></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="fee_009">ROYAL BANK OF CANADA</ix:nonNumeric></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Narrative Disclosure</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">
The maximum aggregate offering price of the securities to which the prospectus relates is $<ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" contextRef="c_report" id="ixv-40">873,000</ix:nonFraction>.
<ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="c_report" format="ixt:booleantrue" id="ixv-41">The prospectus is a final prospectus for the related offering(s).</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">&#160;</p>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !  ),# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#TOQ_XVN?!
MPT\V]G%<?:O,W>8Q&W;MZ8_WJP=,^(_B75H!/!H=BD);:LDTY0,?09Z_A5;X
MVHTC:"B*6=C.% ZD_NZ\^OM2D@M;72I(S]KTF1Q#/"_R[MP+94CG!'4$=*ZY
M4I2HPC12YW>[>MEKK:ZOK9;Z7;L[6/+J5W"M+G;Y5;;OII>SZ7?^1Z!>?%;7
M[&\EM9= MS)&VUBC.1^!JNWQCUI%+-H,(4=22_%<WI/BSQ#J0;38)VDO9V!2
M=RBK$J\MQMZ8ZGVXK7O;G4;#PUJR:WK%K>231!((X#D@G(.?E'J/RKAGB:N'
MG&C6I0<VTK*4KN[2YDN5I+=ZM;,TBW4BYTZDK:[I66^C=_39/<L?\+MU+_H$
M6G_?QJ/^%VZE_P! BT_[^-7EM%?3?5*'\IY/URO_ #'U'X6UB37_  U9:I+$
ML3W"L2B'(&&(_I6Q7*_#?_DGVD_[C_\ HQJZJO JI*<DNY]%2;E3BWV05#+=
MVUNP6:XBC8] [@$_G4U<'X TG3M6\-2ZKJ%M#=WVHS2FZ:=0Y&'(V<]   <>
M_P!*(Q3BY/H$IM245U.[!# $$$'H12UQ']M7[ZWJNAZ3]GL;/1+5"&,?F-(=
M@*J 2 % X[GCWK,M/&VMWUAX3VO:Q3:U+<1S2>23LV2 *5&?3US6BP\G_7E?
M\C-XB"T?]:V_,]%N;F"SMWN+J>."%!EY)7"JOU)X%.66-]NUU;<NX8.<CU^E
M<)J?B34;?0O%-O>1V=S<Z28E5S#^[F60 C<A)YP>>:GM_M-S\1X9(9XX"=#A
M>0>5N##S3D#D8I>Q=FW_ %L_U#VZNDOZU:_0[>JO]HV?]I_V;]HC^V^5YWDY
M^;9G&[Z9KBM6\4ZTFF>(=5LY;6&#2;HVL<#0ES*05#,QSP/FXP.U1Z7<R7GQ
M0TZZEQYDWAZ.1\# R6R?YTU0=FWY_H_U$\0KI+NOS:_0]#HHHKG.D**** /*
M/C-<-:77ARY0 M#)-( >Y!B-<#JL,NG:O!XBMX?.L+N3[1'GH"W+1MZ'.17?
M_&26."\\-S2IYD<<DS,G]X Q$BN&6^N/#>LOYZM=:+>DR;",QS1MSD \;AD5
MTRYDH.FKMQDK/3F5]8I])+XE]WFO)JV]I+F=E=:]G;1ORZ/^D]#PQHFGWETN
MIZ1K$MM/"2YM7B#R*.XZC<#TZ=_6MSS;?Q#H&JV-K*+:!2H9Y+8011D-EN^<
M^N?;UKG;WPK'+=37WA>\5S %E^SAB)$RH8%3W&".ON.:7_A(+/Q7=1:=K<<E
MONE7R9HFQL)P&5AZ$C@]1FOG\11EBY_6:<W)1L]4N>G9\VL;)S\KOOJ]4^RE
M-48^RE%)NZW]V5]-'KR^?RV,E[/PK&[)_:>H/M.-R6ZX;W&3TI=1\.VJ:6^H
MZ9J'VB*(*TL$R;)8U;&&QW!R.:Z&7Q'%8VNGS1_Z'%]LDS#! .8TVKL;YN>I
MY]:D\47MMJ%AJNFP.HO;=_/D*0[/,B4\*3WVAA_WS7=#'8R->FO>Y6]6VI*R
MDHNZ4%W6J>C:W5SGEAZ#IRVNEI9-:VNNK[=4>E?#?_DGVD_[C_\ HQJZJN5^
M&_\ R3[2?]Q__1C5U5=U;^)+U9VT/X4?1!7,KX+MK74+J\TO4]1TTW3%IHK9
MT,;,>K!75L'W%=-7 >%_%^IWFNWL&JM#]@_TC[-*J;3^Y8!L^O# _A3IJ=FX
MBJN%XJ2W->\\#65S>+>1:AJ-K=FV%K//#*-UP@ 'S[E.3@#FN:U_PH=/U'P9
MI6EM?+:VT]P3<H SP[F5LD[<#DG&1VK4\&>-;C6/[;EU8Q6\%FL=Q&0,;(74
ML,^I  JY:?$"QNK[3K;^S=2B34G*VD\L2JDH'5OO9QT[=Q6Z]O"5GK;_ "9S
MOV$XW6E_\U^;18C\$Z<N@ZCI4ES>2_VB_F7-R\@,KMD'KC Z>E37?A.TNM3M
M;];V_MIH+=;8_9IMGFQJ<@-@9Z^F*AT?QG;ZY?FWLM+U)HEF>"2Z:-!%&ZC)
M!.[/IV[BJ7A/7V3PUH,$ZW=]>WHDY4AV55<Y=RQ&%&0,_0"LVJJNV]?\U_P#
M1.B[)+3_ "?^;)]2\!:?J5S?R?;]0MX=0*M=6T$BB.1EZ'E20>.QK0L_"UC9
M:U;:I'+<&>WL5L45F7:8U.03QG=^./:J=]XYTVPN[F.2VO6M;258;F]2(&&)
MSC@G.3C(S@'&:;%XENF\=7.CBUEN+-8(722! 1&6R2SDGIZ8!H_?-:[6_P O
M^ '[E2TWO_G_ ,$ZFBN:A\:6=SJ+6UK8:A<PK=?8VNX80T2R\9!.<X&1SC%=
M+6$H2CNCHC.,OA84445)1Y'\</NZ'_V\?^TZ\[T/Q ^G-]EO4^UZ7)Q+;/\
M, /5<]#]*]$^.'W=#_[>/_:=>?KX1OO^$>MM=EN+2&PN'V1R22'.[)&" #CE
M3^5>S"C1K814ZRT?WW[I[IKHUJ>#B)5(8F4J>Z_K7R-.^T%;*\FU+PS?B46H
M69H Q\Q$*ALC^\N"/Y<TZYU72_&-V(+F(:=>LP%O<J,JQ('RR?CG!_R<:XT'
M5=&UVQM'DCCN;D1R6TT<NY&5SA6##MFM6X\#:K?>(+ZRLQ8_;81YLEG'-@H#
M@_+D $?,._&17"L!K&56K>45[L]I+RETDK]UW3ULR_;2U4(63>L>GRZI^GDU
MV.?EO;^&Y:VEN9(S%*X;:Q^4D_-^HKI;W4Y_[,U#46N;@6]X&M[:WFB"[P>K
M Y)("]\=2*H646N:Y>W<VFW4T$=O&LES*]SY21\ $DY[L#2ZA=:FOAV5+K5K
M;4K62544B8R21..<_, P! (STJZV$E5=-\D=&KKK:Z;M[MKW2ZWMMJR*=7D4
MM7UM^7?S[;GM7PW_ .2?:3_N/_Z,:NJKE?AO_P D^TG_ ''_ /1C5U5<U;^)
M+U9[-#^%'T05Y]/X)U5_!-IIL,UO%J0N)FFEW';Y<I<. <9/RLOXK7H-%*%2
M4-ASIQGN<#<>!;M]8U_[-)!#I^HZ<EM%\QRCHJ*N1CIA32KX;UV[U#PK)=6]
MI FAY25EG+><-JC<@V\?<Z''6N]HJ_K$_P"O2WY&?U>']>M_S.8\$:!>>'M/
MU""],1>XOY+A/+;(V,% SQUX-9'AWPAJOAB6QO+4PS2O$8-0MVF(4C<2KQG'
M!&>G0_K7?44O;2NWWW*]A&R7;8X>'PK-;7VI1W&BZ?J=O>7DES'+--MV!SG:
MZE3T/0C-:-KH]_I_C6ZO[>VMVT^YMH8?];M,6S(P%VG/'3I73T4.M)[_ -?U
M8%1BMOZ_JYP&I>$]5GU^&_TF&+2)Q<;YY[>Z)BGCSGYH]HRY[]CSDFN_HHJ9
MU'-)/H5"FH-M=0HHHK,T/(_C@"4T,XX'G_\ M.DL9M)@^$'A]M;M3<6#7S+*
MH=E*CS)?F^4@G'I7INK:'IFNVX@U.SCN8QG&[(*YQG!'(Z#IZ5P6L?!^"YB9
M-*U>XMH0=R6L^9(U/MR".I]:]&E6ING&G)VL[_G_ )GFU:%15)5(*]U;\O\
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144 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $S I8# 2(  A$! Q$!_\0
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M_P ]D_.C[7;_ //9/SHN@)J*A^UV_P#SV3\Z/M=O_P ]D_.BZ FHJ'[7;_\
M/9/SH^UV_P#SV3\Z+H":BHEN8&Z3(?\ @0J6G< HHHH **** "BBB@"KJ-]'
MIMA+=2\A!PO]X]A7F6H:E<ZG<F:YD)Y^51]U1Z 5V'C=F&E0*#P9AD>O!KA*
MWIK2YSU6[V"BIH+2YNMWV>WEFV_>\M"V/KBH>AP:U,0HJS;V%U<N$BB^9D+J
M&(7<HZD9QGH>GI5:@ HHHH **FM;66\G6" *TC= 7"Y_,BB:TG@B261-J.S*
MIR#DKP: L0T444 %%%3O9SI9I=%1Y+L55@P//H1G(_&@""BBB@"6WN)K699H
M)&CD7HRG%>CZ!K U>PWN L\9VR*/T/XUYG74^!V(U"Y3/RF($CW!'^)K.HKJ
MYI3;3L=S1117.=04444 %%%% !4<TR01&1SP/UJ2LO5W.Z).V":F3LK@5+B]
MFN"<L53^Z*KT45R-M[E!1112 **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ J:"ZEMSE&./[IZ&H:*:=@.AM;E;F+<O!
M'!'I4U8VEL1=%>S*<ULUU0ES*Y(44458!1110!R_CC_D&6__ %V_]E-<+7=>
M./\ D&6__7;_ -E-<,JL[!5!9B<  9)-=%/X3EJ_$;'AZ&65[_RHW?\ T21?
ME!/)Z#ZFI-3MQ'HT+&V%NRE 5>%07.T\JX^\#U(/2LTZ5J(.#870.,_ZEO\
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M]/K5FUTJ26X>"Y$UM((FD0/$?FP">Y&.G6C;6X-WTL9U=1X'_P"0G<?]<?\
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MDUJ]O?.]HZVMEY<32JTT@1BP^[P=QZFAI7!-I"W5_IMW#<L]T0+B2%C%L;<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M )XO_P!\UT-%'LEW"YSWV2X_YXO_ -\T?9+C_GB__?-=#11[)=PN<]]DN/\
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M_P#WS70T4>R7<+G/?9+C_GB__?-'V2X_YXO_ -\UT-%'LEW"YSWV2X_YXO\
M]\T?9+C_ )XO_P!\UT-%'LEW"YSWV2X_YXO_ -\T?9+C_GB__?-=#11[)=PN
M<]]DN/\ GB__ 'S1]DN/^>+_ /?-=#11[)=PN<]]DN/^>+_]\T?9+C_GB_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445'/(T5O+(D9
MD=4+*@_B('2@#G?$/_(PZ)_UU_\ 9EKIJX.]UN'4KW2+MP(FAF_>KG.T!E.?
MIBNHT35GUB&:;[.8HUDVH2<[A6DD[(SC)-LU****S- HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHIDL
MT<"%Y&"K0 ^BL>;66)(AC 'JW6JQU.[)_P!;C_@(_P *GF0['0T5SW]IWG_/
M;_QT?X4?VG>?\]O_ !T?X4N=!8Z&BN>_M.\_Y[?^.C_"C^T[S_GM_P".C_"C
MG06,;Q!X>E&M1?9$_=W;<8Z(W?\ #O\ GZ5V=E:1V-G%;0CY(UP/?U/XFL7^
MT[S_ )[?^.C_  H_M.\_Y[?^.C_"J=6ZL2H6=SH:*Y[^T[S_ )[?^.C_  H_
MM.\_Y[?^.C_"IYT58Z&BN>_M.\_Y[?\ CH_PH_M.\_Y[?^.C_"CG06.AHKGO
M[3O/^>W_ (Z/\*/[3O/^>W_CH_PHYT%CH:*Y[^T[S_GM_P".C_"C^T[S_GM_
MXZ/\*.=!8Z&BN>_M.\_Y[?\ CH_PH_M.\_Y[?^.C_"CG06.AHKGO[3O/^>W_
M (Z/\*/[3O/^>W_CH_PHYT%CH:*Y[^T[S_GM_P".C_"C^T[S_GM_XZ/\*.=!
M8Z&BN>_M.\_Y[?\ CH_PH_M.\_Y[?^.C_"CG06.AHKGO[3O/^>W_ (Z/\*/[
M3O/^>W_CH_PHYT%CH:*Y[^T[S_GM_P".C_"C^T[S_GM_XZ/\*.=!8Z&BN>_M
M.\_Y[?\ CH_PH_M.\_Y[?^.C_"CG06.AHKGO[3O/^>W_ (Z/\*/[3O/^>W_C
MH_PHYT%CH:*Y[^T[S_GM_P".C_"C^T[S_GM_XZ/\*.=!8Z&BN>_M.\_Y[?\
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M#RN,4<HKZ7.OHJGIC.UD"]_'?'S'_?QJH'WC\N%X^7[OX5<J1A1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% %[2?^/X?[IK>K!TG_C^'^Z:WJUCL2PHHHJA!1110 4444 %%%%
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M+6*('(7J<GU/ X' J_10!'#!#;1^7!%'%'DMMC4*,DY)P/4DFI*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** +VD_\ '\/]TUO5@Z3_ ,?P_P!TUO5K'8EA1115""BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#-UG_CVC_W_P"E8M;6L_\ 'M'_ +_]*Q:REN4A&;:I8YP!GBN9T'Q+<ZD+
MN]N[>&#2@/-CNC<KB)=B-MD! VG#$YRP'()&!GIGW;&V$!L<$C(S7&:/H6K6
M_B+4]8DMK&WN&0QF*"5UCNW*1X=B4^4 @] Q!9ADXY2Z^@^AUEI?6M_91WMK
M,LEM(NY)1T(]?I5&Q\2Z1J,CI;7>2L9E!DC>,.@ZNA8 .O\ M+D>]8VFV6L6
M.D:7X?NTL=LD<T-PT$KNPCVG:ZY5<<D @CN,4U/"^IWT,-MJDUI%#:V$MC$]
MJS,TN]0N]@0-F H^4%N3UH:W!>9MV?B72+Y9FAN]HBC\YC-&\68_[XW@;D_V
MAD>]2Z;KNG:N\D=G,[21J&*20O$VT]& < E3V8<'UKGYO"^IZO'(NJ36EN4T
MZ2PA-JS/NW[<R-N"X^X/E&>_-:>F:;J9UG^T]4^QQO':_98X[5V<,-P8N2RK
MC) PH!QZFG9"UL;)N(A=+;%OWS(9 N#]T$ G/U(JK?ZF+.ZL[2*+SKJ[=A&A
M;: JC+,3@\ 8['DBJ,GAF"3Q FI>?>@!&RHU&X WEE(PH?:%X/R].G%+JMM*
MGB#2=42-Y(8%F@F"*691(%PV!R1E #CUI*V@^Y!::]>WOB2>UM[))+&$^5(_
MG@21L"P+%"OW>!_%GH<5L6.J6.IF<6-U%<"WD\J4Q-N"OC)7/3/-<S+H.I7G
MC>#49X;.!;7YEO+<N))H\MB)E(QW&?F/W00!GA\46OZ1=ZG<^1II_M#48GB1
M9Y'8H0B,,;%^;:I;.2!SG@9II)I?UU![LVD\1Z5)J7]GK='SRYB!\IQ&7'5!
M)C86']T'/M20>(]*N=1^PQ71,^]HU)B<([+]Y5<C:S#G(!)&#Z5CP^&]322"
MQ:2T_LR#4&OEF#,9FRY<(5VX'S-][<>!THM/#>II)864\EI_9UA=/<Q3(S&:
M7.[:I4C"XWG)W'..@S2T$S9M/$6E7U]]CM[HM,2P7,3JDA7[VQR KX[[2<5?
MDNK>(R"2>)#&GF.&<#:O/S'T'!Y]JYC3?#FI03:1;74EI]ATAV>"2-F,L^59
M%#*5 7 8YP6R1VK5U?0_[6N89VN!&UL-T $8(#YSE^?F7@?+QZYR 0[+0?5E
MZ]O[?3[4W-P["/( V(SLQ)P JJ"6)] #61;^+]/N=7>R6.Y2);87'VB2VE1
M,MD,60!0 O4GKD=15S7[&?4=*-M%;6MR6=2T=Q,\((!SE70%E8'!! [5AOX5
MU&>TEM;F\25;O3FLIY'D9I(_F<J02/WGW\$G:3MSWQ25NH&Q%XHT>:UFN%NF
M"0[2RO!(CD-PI5"H9@QZ8!SVS5!_%D2:E'-YR-H[V<LQ*VDOG1O'(B,".O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** +VD_P#'\/\
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M% !1110 4444 7M)_P"/X?[IK>K!TG_C^'^Z:WJUCL2PHHHJA!1110 4444
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MDETRVD\QD1<9:3A=@'R^F<GGJ:W[;P]HEG/'-:Z/I\$L2E8WBMD5D!SD @<
MY/YFGVNB:38W N+/2[*WF"E1)#;HC8)R1D#.">:KF0SE#JNJV-X\_P#:TUZ%
MU8V0LGCA&Y",\%5#;ESGKC Y'>HK/7M:EMK*5-1AEFU/3Y;D13*B+:R J%4$
M#IEMOSY.1^%=#HWAM=-U6_U&Y^P7%U=2F19X[+RY44]4+EF+#@>G?\-#^Q=*
M NA_9EGB[_X^!Y"_OO\ ?X^;\:E-6%U./GUC5TTM'%]J*&U>7[<&BMC=1!0I
M!*XV21@$DE,,<KCO4=])/<7,\4MS#&Z>((%2>"!8V :)2I.<Y8!L9.<XZ=J[
M ^'M%*6R'1]/*6I)MU^S)B(YSE>/EY&>*<=!T<_:,Z38G[2V^?\ T=/WK<\M
MQ\QY/7U-.Z_KY!TM_74X\7-_JEWID1O3]K@O;VUAOEC3+;8F ?&-N<\'C&0>
M*W/"UY?:E$+JXO9I!% EO-"Z1@"Y4GS#E5!XX'7'7BM.?1;%HX&M[&P2XM5(
MLY)+57%N>VT#! ]@15BPM!96BP[M[DEY'V[=[L<L<=LDFB^@K:W.&U'7)[N3
M5K6.YN+C3KG3+V1/M"1 *T1"GR]@#;<L1\^3\O'OI:-/!:>)+R:XECAB&DV.
MYY&"@<R@9)_"MZ;P]HMQ)))/H^GRO(279[9&+$C!))'.0 /PJ"Y\+:--;30P
MZ986YGC6&1X[5 QC!'RY '8#'I@'M332*>I#KUW=C5-+TVVO'L4N_-9[I$1F
M&Q00@W@KDY)Y!X4UB:'/>:OXBTC4;F^E5VTZ8F*-8Q&X$JKD97< W#<'L.V<
M]C>:?9:C;?9KZT@NH,@^7/&'7(Z'!XIG]DZ;]NCOO[/M/MD2[([CR5\Q%QC
M;&0.3Q[THNPI*YQ7B"VD5/&\C:A/(O\ 9ZG[.PCVC*-CHH;C!QSW.<U+>Z]J
MNFVNH6D=P]P\5Q:11S+'$)(UF S]XJF1T7=ZC.:["\TG3=18M?:?:71*;"9X
M5?*YSCD=,@''M446@:- )A%I%A&)T$<H2V0>8@Z*W'(]C0GI89SM_+JES\.-
M9&H336]W#%.N_,)D* $KOV;D#%< X]>,4R?5KG3]0TVUM=1O+D136]M=+,D
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MER" H/;.3P#6+H.F#[;X;OM0TF5[B*RDMGGFLR9(Y59=FXD948#X;ISUYY]
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
>HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &( E # 2(  A$! Q$!_\0
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M.!71SV\%U$8KB&.:,]4D4,#^!J2B@#S[X.JJ>#KM5 "C5;L  < >97H->?\
MP?\ ^10O/^PK=_\ HPUZ!0 4444 %%%% !1110 4444 %%%% !1110 4444
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M\'_^10O/^PK=_P#HPUZ!7G7P6G6Z\"S7"JZ++J5RX5QA@"^<$>M>BT %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !144US!;
M*#/-'$&. 78#)]*IN;W4/M5OY<ME"#M2X#C>^#R5&#@$9Y///2@">XU&UMKJ
M*U>0FXE^[&BEFQG&2!T'N>*J_9+S44E34BD4#,"D-O(P;'.0[#&0?05>M[:.
MVC15W,57;YDC%G(Z\L>34U #(88[>%(845(T 5548  [4^BB@ HHHH ****
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MYNYK.RMY 40YNI%_=JQ'  X+?A44>ESZE:JNO""8B7S%ABR$7C@'^]^-:P
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MEG8X %'MO[J^X/9?WG]YR/\ Q7G_ $X?I5+4=6\8:4B-=RV*M(VV-%7<SGT
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M* "BBB@ HHHH HW3,-4T\!G"DR9 F"@_+W4\O^'3K5ZJLX8WUH0'V@ON*HI
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M1^#_ /R*%Y_V%;O_ -&&O0*\[^##R2>")WFB\J5M3NB\>[=L._D9'7'K7HE
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M&VCL-A3[*D2B+:>HV8Q@Y/&*M44 5I-/LI;^*_DL[=[R%2D=PT2F1%/4!L9
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MA_A^O?\ "K% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MTXR3R/P_&K%5YE4WEL2JD@M@F$L1QV8<)^/7I5BD 4444 %1R*QDA(S@/DX
MZ;3US_3G\,U)4<@!DAR </QE"V/E/0_P_7\.] $E%%% '/ZUK-[;>(]'T6R^
MS1O?QW$AGN%+A1$%^55!7))?/7@ UGZKXHU"RTW4[Z$Z>Z:;ID=](HW2+<%@
M[$(X(PN$P&P<YSCC%;FMS:+%' NLK:R"1R((YHA(S-@D[%P23C).!TS5:\N/
M#31VUU=1V,D1B1XIV@#HD9/R'?@A%)Z$D#TZ4 9$7B?5KF0R(+.*!M4%@J-"
MY<*T0<,3O R">F.0.U8NC>)M3L/"6EN/LUQ='2K67SYT9F8R3B,[CNR>#GKU
MY]J[^[33+&(SW$%NBF=9,^4"6F.%#  9+G@#'-9[2^&;>RA?[/9B"0,B(EKD
MXC<LP*A<@*X).1\K=<&@"A:>(=5O-8DT@&RCGBNIXFN# Y5E2.)QA-^0Q\T?
MQ'A3Z\8NC^/-=UBTE,5E9F:WLFNI'7 C<^=-&HR\J[5Q#RV6^]T&.>AO5T74
M]0AM+6[TO[1(WV@Q26J3I,SI\KYX^?8I(PV2H/! XFT+P[H,/A^RM;>""^MH
M%9(YYXD<MEB6/W0,%LG@ >G% &?<^(-3MM1N9U2W^R#4;2Q$;1Y8B58R3O#=
M09?0C &.I-:7@M[B7PK:/=3":5FD)?!&?WC=<DUI?8;.6[G,EI;N6>.5B;?D
MNOW6+'AB,#'=<#VJ.SN])@TJ:[M3!;V$9>1Y%3RX^,EGZ $=3NZ'UH X?PU?
MW\.\&2Q:YN]0U3-U<0L3'Y4K!<G?G:.F,C &/>I-*\>ZMK+Z3':VMIYFH_:G
MVJI9H%A*KL(=TW.2VX\C ['K7816F@WPGM8[.QF6)F,L?D*0#*-[9&/XLY/K
MGFK$NCZ9.S--IUG(6?S&+P*<M@+N.1UP ,^@Q0!Q&MZYJ^I>$==1C;6<EI8!
MIB@WEV)D!*,KX4?)_M$$D'I76:[J%W80Z<MGY DNKR.W9ID+A58$DX!'/'K3
M;VR\.+/9Z==Z?8/++&8[:!K57_=KC( P<*-P]AD5K2P0S>7YL4<GEL'3>H.U
MAT(]#[T <<_B77A))(EM9-;1ZDMBS.4C&-X0L&:;.[)W!-N2, $DYK.\,>)=
M1M_",0F>*=[;PZNH"60,6>3Y_O$MR/E&>YYKNFTC36O?MC:?:&Z#!_/,*[]P
M& =V,YQQFHVT+1WB2)]*L6C12J(;="%4G) &. 3UH Q-6U[5K.#5[BW-EY=G
M=06T220N2WF"$DL0X_YZG@#L*V=*N[JXGU&WNVA9[2X$0>)"@8&*-^A8\_.1
MU[5;DLK25)$DM8765U>16C!#L,8)]2-JX/L/2I$BCC>1TC16D;<Y5<%C@#)]
M3@ ?0"@#E;/Q+J%V8;C;:K;SZK/IRPB-C(GEM(H<MNP>8\D8'!Z\<W?!43IX
M5LI93$TTZ"621(]I<GNV2<GWK673+!+PWBV5LMT229A$H?)&"=V,].*GAABM
MX4AAC2*)!A410JJ/0 =* 'T5#%=V\\\\,4R/+;L%E53DH2 P!]#@@_B*FH *
M*** "BBB@ HHHH **** "BBB@ /2O ;KP]XEEUO6(;/0M:OQ<)";^$>*HTVL
MT*EHG'5@ 2H)Z@<<5[]7D7CC3=9T_P 0:SKMG9^*([+R4DGN--U>UAB98XQD
M^6R%\@9]3Z<8H ]5L(S%IUK&8!;E(47R0V[R\ ?+GOCIFK%5=-D\W2K.3<[;
MX$;+L&8Y4=2."?<5D>((?%\KR+X?NM'AA:W95^V12&02D'#!E.T ':>5/0T
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MX-L[JVU37IKN&Z22YEMI0\V_#_Z/&&(SQPP8$#I@#IBNNHHH **** "BBB@
MHHHH **** "BBB@ KRSQB= NKWQ6^I6P,VFVL<@AN=6N(4O"8RQ C5PNW "C
M .6SD>OJ=>&?%#6=4M?B';*VE6TL-M [V3OI(NFD?RBR?.5)YE^7 (QC)ZT
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#8RO]XG*_AUZ5:DBCF4++&CJ&5@&4$!@00?J" 1[B@#S^W\.W-QXAMIY=/\
M^)0=8EN(;:2/"PQ?9/+W%#]T-("0,=3G&34-_P"'[^ZCMK:UTYTO8[N]>]N"
MFT30,LP12_1PQ>+"\XV\XVUZ310!Y>FBWBV\D<>CG=);VBV;?8R'C=0%<*Y8
M>3M<%R2O.[(W=*T!HTRK=VMUICW&I37E\PNR<!X9$D,8+$?.,,B>7G@KGHM>
M@5!.I::V(&=LA)^0-CY&'7^'KU'T[T ><P:)<QR)*-&EDL$BTX36PBV>8$\X
M2?(<;MK,KD8YQQG-3Z1X=N9?%?VFZTDQZ0UW=R6UO,H*QH8X5!V?P;F61@N
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MI+X>?]"]_P"3MQ_\<H [#^W='_Z"MC_X$)_C1_;NC_\ 05L?_ A/\:\[\1?
MCPE>Z%<V^A:='I^I/M\FZDN)Y%3# ME2Y!RH(Z=ZU/\ A27P\_Z%[_R=N/\
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M* .P_MW1_P#H*V/_ ($)_C1_;NC_ /05L?\ P(3_ !KC_P#A27P\_P"A>_\
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M8_\ @0G^-<D?@O\ #]HUC;0F,:$E5-]<84GK@>9["F?\*2^'G_0O?^3MQ_\
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M /05L?\ P(3_ !KC_P#A27P\_P"A>_\ )VX_^.4?\*2^'G_0O?\ D[<?_'*
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M!9)&EE4)R46$)P_)8J.YKH)?A_H\OBB'7/,O%,1C?["LV+5I$7:DC1XY=5P
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M(+>7>ORIA0-NU\#?NY YYK5D\9S:7JL%CK.I_95M)I);TM"LDAB;>8(V\M2
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M+9VJ,#K79US\O@[3)-=M-4#3Q_9O+*VL940L\:LB.1MW9578#! Z9!P*Z"@
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MJSL !^)I?,C\T1;U\PKN"9Y(]<>E #J*** "BF/-'$K-)(B!1EBS 8'J:?0
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M,<*!9&N(]Q^YP!UY]*].HH Y&PU?4;[Q,^AFZ>*73KB2:Z<QJ3<6Y ,('RX
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
8@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_007.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_007.gif
M1TE&.#=A*0)@ 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M>\!LU[5Y"Q].O+CQXPGIT4:-O+GSY]"CF_0-<@!&?LRE:]_.O;MW -0[#O^
M<:.!@0 W;CP 8* \NH$/*J!N/\& 0'O9O^O?S[\_Z_ <#1"!.S X0$  Z!GP
MP (SU"!0 ! $T,  "RX @T#!^:?AAAQV^!%I'@W00@/O+6#$# #< %X# LV
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M-M\;H&D"1X &-B W#6[P7VXG_H-\?[+%4_1XAXB] A/@>XLS?P!Z&($"_SC
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MGQ81$< E"?\@']@%@G1H+YJ&$#?0AP>A=A0 (FM($#HV>BBVA0NQ(/R&;Q4
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M7];V I%:$0<VH/^@3)&(J?M"8#X'HPCQ $/8$%H'A0*1?C%AHP%@!#0P !!
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M^P8=8 YVRP ^JP!VB[=ZH+9 JP!0T %04 EJ<+B 2[1(N[<*$ AJH >'JP:
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M@(9S>V-U1>=TA^H0 #H!,+L1-HI)X5,!&_M;\RI>!,9S GH0H-HK"U=^Z'8
M5@AOC.)?=U5T,DH!>]EO)6<#^J<1P!81 8!Y>^H1_W:@"R?%,8L0%2 !GKLA
M$0!Q#_"G'-;"J*%U9E<#ON9W?241  J?X4H15.B: 4"D_&,?^6 HY>@/MM1)
M[#@;_5 ##NELA!J0F/^HG$AG*Q% @5#:<Q)  ^U%&EI7>FES=DDY$0#Z9,4T
M28L($0:@3 ;@#NAP#Q26 $9 /S.0:C> #J!: UPB(;M42[*L/HF\:4:G$$PV
MQAHRJ@X 9QLV;^ A=KM&8GMX *\D$2W,:1O1#P5[$!!PE5Z<=@7A.P!@8I1I
M/OEP40 P \T$(3(A31]7 .AP31%D !&4SNML .9LSM?$#P; #]O4SNI\S_<<
M0>]\SO-\S_L<S_-<S_ALS^W\S_U,S_G\0 3MS^@ S_VLSPW-S_*,T O-S@SM
MT!,MT!:]T>X<T0 -T1@=T D]T@7MT0>MT0H]T!<MT2L-T!2MTAQMT/(,TBS_
M3=,?W='F;  S(,6WEM#M'$&4YGW<%,\"S=!$K=(87=00?=06G=1(+=%*W=%,
MG=(A7=42+1-&&7*!N&$/( _@.1XRER!&(%%%AP#]O,]H'='YW*@-\-+W+,\Y
M;=%P_=4/=,KS.8[N0 ]9P0Y=*1 10CY;(B-J8IE<YCLRPE'\]E$F-5(&L)B,
M/5*+R5(G]4"03=F-;=F1;0#Z\$ DQ=B3;5*8'=HB==F2#=JC'=F5?=J<O=DK
MY=F@;=JI'=ND_=F<K=JVG=J:S=DAY=JZ7=NRC=JS_=J^3=J_O=J]S=N2?=O$
M'=S'W=NM[=R=[=SF2@/AUMR[;0 PL _EMDVU7=N9_]W=G/W=X#W;XTW>XRW>
MX(W>W2W>ICW9#X0 "Y  [54>_K4.$M)QW TFLL=@#B"%(+4 W6U2K,W:+]6H
MV+G>M6W:WVW:]_"/%7%P-\MJ:VPF-^ .7>4 8RE69'567H7+;%H#%2!V(TP0
M$OK"F#(#$'< \J=UI+%P!R<BLW< %$A9)4ZN-%P1V'P0#M "@%4\-Y"D\8-E
M>^4JLP<>B1)8"J9CPAH2DU)T9C< )TL0";JEONP=HTJN6J<<MO8Q," W.!?-
M"M'"C@H_8"X;GZ305)IA[G  J.D1(Y:6-C<0#K /!3$ $'=SI\HAC3JE+/[-
MFTP07:ZA SL1MYK# W''$O]Q S;P E&WGAFQQ=.%#IWW$:/*(A$ H=$DBP.Q
MYA0PJCM<&F(EYHW<PJ3AGH!> 8).6=A8Y0Q!H [A%?_(ZF;ZZ7)$;F7.$ Z
M9:FIQ.1SA\]Z $N>#Q2( -2=>1U";C5.(PSVBD!, RW =QM+B^E EACA#[?^
M6[+^$)>J7/X@=I^F8YG;$#=@PN^Y=4;Y2@Y(KO@CHQA'=K3N$O[ 8)OF<P3Q
M +MV$#! =YS'[$\#;]F>$'HD0$X(CVFN8/Y50 >0YWD7LRVL(@]K'YIF:Q5
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M_ULVVN6HGC^G&" POT;@QASDMF(WRZKD8W*''(&U:.S%,^DRWZL7PGFM#*V
M[E^E^?:X&AT%0,2=OQ!S[/+:"+(2D:KY$OME-,?C0WL$_X:*#'9T.-=) 3"!
M#+>LIG\?(@ZN_(9N"1JS_V!G4A>D1"\=#Q\!2_X0[R8!U/_T"W"S[2K]  %
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M@3]B5(%-;W//#GG-2 /[Y5.3MR1*$5H-:+!H"A@9DF )=4FB9T$$&^XI-*A
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M<5OI 251>\8Z/9$-OM9?&H);,=7IKWL8:_$#"6_;P6P#H<!GZ A#P, ^B#D
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M7PJVX K&8/.M(R4Q GZ ,0.PNSB97RUIC_D%W@Q&X0M6X11F8?7%W@ 8%K!
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M S<>9B2(*:8-4C*!Y4SS,Q ('5T"\$R-)& H^.'D8="Q'"/, P846(XN?32
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=U\R%%O6B+@:C, XC,1:C,1XC,B:C,BXC P8$ #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Dec. 19, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001000275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">ROYAL BANK OF CANADA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-275898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Dec. 19, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 873,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>11</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp238986_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dp238986_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="dp238986_exfilingfees.htm">dp238986_exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="9">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dp238986_exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "dp238986_exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 11,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/dei/2025": 1,
    "http://xbrl.sec.gov/ffd/2025": 6
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 9,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp238986_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp238986_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:NrrtvMaxAggtOfferingPric",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp238986_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:NrrtvMaxAggtOfferingPric",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp238986_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0000950103-25-016375-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-25-016375-xbrl.zip
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MO_^JG^4O4Y*CBB:?//#R25Y#M7\ 4$L! A0#%     @ ;G636RDUM44%!@
M$Q(  !D              ( !     &1P,C,X.3@V7V5X9FEL:6YG9F5E<RYH
8=&U02P4&      $  0!'    / 8

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>dp238986_exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001000275</identifier>
        </entity>
        <period>
            <startDate>2025-12-19</startDate>
            <endDate>2025-12-19</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="fee_001">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="fee_002">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="fee_003">0001000275</dei:EntityCentralIndexKey>
    <ffd:RegnFileNb contextRef="c_report" id="fee_004">333-275898</ffd:RegnFileNb>
    <ffd:OfferingTableNa contextRef="c_report" id="fee_005">N/A</ffd:OfferingTableNa>
    <ffd:OffsetTableNa contextRef="c_report" id="fee_006">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="c_report" id="fee_007">N/A</ffd:CombinedProspectusTableNa>
    <ffd:FormTp contextRef="c_report" id="fee_008">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="fee_009">ROYAL BANK OF CANADA</dei:EntityRegistrantName>
    <ffd:NrrtvMaxAggtOfferingPric
      contextRef="c_report"
      decimals="INF"
      id="ixv-40"
      unitRef="USD">873000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c_report" id="ixv-41">true</ffd:FnlPrspctsFlg>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
